ArticleFrontiers in immunology2022

Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients.

Raffaella Marocco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.